Acceptance and Opinions of Intanza/IDflu Intradermal Influenza Vaccine in the Czech Republic and Turkey

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00179906%3A_____%2F12%3A10130899" target="_blank" >RIV/00179906:_____/12:10130899 - isvavai.cz</a>
Result on the web
<a href="http://download.springer.com/static/pdf/689/art%253A10.1007%252Fs12325-011-0090-5.pdf?auth66=1362815588_84b2d2c58a49c413804aff480ef6fc77&ext=.pdf" target="_blank" >http://download.springer.com/static/pdf/689/art%253A10.1007%252Fs12325-011-0090-5.pdf?auth66=1362815588_84b2d2c58a49c413804aff480ef6fc77&ext=.pdf</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/s12325-011-0090-5" target="_blank" >10.1007/s12325-011-0090-5</a>

Result language
angličtina
Original language name
Acceptance and Opinions of Intanza/IDflu Intradermal Influenza Vaccine in the Czech Republic and Turkey
Original language description
Seasonal influenza is a threat to public health with a major socioeconomic impact. Worldwide, influenza si responsible for 3-5 million cases of severe illness and 250,000-500,000 deaths each year, most of which are in high-risk groups, including the elderly (}=65 years), children up to 5 years of age, pregnant women, and people with certain chronic diseases and conditions.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
EC - Immunology
OECD FORD branch
—

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2012
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)